Clinical Trial Update: A Study Of Pembrolizumab In Combination With Trastuzumab-DM1 [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating the safety and preliminary efficacy of pembrolizumab in combination with ado-trastuzumab emtansine (Kadcyla) for breast canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Pembrolizumab (pembrolizumab)
• Trastuzumab-DM1 (ado-trastuzumab emtansine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED | Results posted: 2024-12-02